Literature DB >> 7607087

Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs.

D Carrasco1, F Weih, R Bravo.   

Abstract

We have studied the expression of the c-rel proto-oncogene during mouse embryonic development and adult animals using in situ hybridization and immunocytochemical analysis. c-rel transcripts were detected late in development with an expression pattern that parallels the emergence and diversification of hematopoietic cells. In the embryo, c-rel is expressed first in the mesoderm-derived hematopoietic cells of the liver and later also in other hematopoietic tissues such as thymus and spleen. This correlation between c-rel expression and places of hematopoietic infiltration is conserved in the postnatal period, with expression of c-rel mRNA in the medullary region of the thymus and in splenic B cell areas, including the marginal zone and the outer region of the periarterial sheath. High levels of c-rel transcripts were also detected in the splenic germinal centers, lymph nodes and Peyer's patches. Using double immunofluorescence and cell preparations from different embryonic and adult hematopoietic organs, we have defined the pattern and cell types of c-rel expression in different hematopoietic cell lineages and in the stromal cell content of the thymus. By using electrophoretic mobility shift assays, we have also correlated c-Rel expression in spleen with kappa B-binding activity in the form of c-Rel/p50 and c-Rel/p52 heterodimers. The timing and pattern of expression of the c-rel proto-oncogene in the different cell lineages suggest that temporally regulated changes in c-Rel expression may be required for vertebrate hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7607087     DOI: 10.1242/dev.120.10.2991

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  24 in total

Review 1.  NF-kappaB and apoptosis in mammary epithelial cells.

Authors:  R W Clarkson; C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

Authors:  J Bash; W X Zong; C Gélinas
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Identification of nucleotide sequences that regulate transcription of the MCF13 murine leukemia virus long terminal repeat in activated T cells.

Authors:  F K Yoshimura; M Cankovic; R Smeltz; S Ibrahim
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

Authors:  C Chen; L C Edelstein; C Gélinas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

7.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

8.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  c-Rel gain in B cells drives germinal center reactions and autoantibody production.

Authors:  Maike Kober-Hasslacher; Hyunju Oh-Strauß; Dilip Kumar; Valeria Soberon; Carina Diehl; Maciej Lech; Thomas Engleitner; Eslam Katab; Vanesa Fernández-Sáiz; Guido Piontek; Hongwei Li; Björn Menze; Christoph Ziegenhain; Wolfgang Enard; Roland Rad; Jan P Böttcher; Hans-Joachim Anders; Martina Rudelius; Marc Schmidt-Supprian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

10.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.